Literature DB >> 10266241

Cost of wastage in a hospital intravenous admixture program.

D J Salberg, R W Newton, D T Leduc.   

Abstract

The wastage in a hospital centralized pharmacy intravenous admixture program was assessed. The loss rate was similar during two separate 36-day study intervals, averaging 6.2% of intravenous admixture preparations, accounting for an estimated loss of $26,077 for the year. Discontinuation of intravenous therapy accounted for half of the returned intravenous admixtures. Patient unavailability, drug changes, and malfunction of intravenous equipment were also causes for returns. Improved communication between hospital ward units and pharmacy personnel as well as increased flexibility in admixture preparation scheduling may reduce wastage. Ultimately, pharmacists assigned to individual ward units as part of the unit-dose pharmacy dispensing system may resolve the problem.

Entities:  

Mesh:

Year:  1984        PMID: 10266241

Source DB:  PubMed          Journal:  Hosp Formul        ISSN: 0098-6909


  7 in total

1.  Direct costs of intravenous delivery systems.

Authors:  S W Birdwell
Journal:  Pharmacoeconomics       Date:  1993-07       Impact factor: 4.981

2.  Survey of wastage from intravenous admixture in US hospitals.

Authors:  S W Birdwell; G E Meyer; D J Scheckelhoff; C S Giambrone; S A Iteen
Journal:  Pharmacoeconomics       Date:  1993-10       Impact factor: 4.981

Review 3.  Treatment of urinary tract infection. Clinical and economic considerations.

Authors:  R J Plumridge; C L Golledge
Journal:  Pharmacoeconomics       Date:  1996-04       Impact factor: 4.981

4.  Identifying costs of intravenous solution wastage.

Authors:  K M Uchida; S A Iteen; N T Wong
Journal:  Pharmacoeconomics       Date:  1994-09       Impact factor: 4.981

5.  Cost evaluation of a new iv device in an Israeli hospital.

Authors:  A Lustig
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

6.  Ready-to-use injection preparations versus conventional reconstituted admixtures: economic evaluation in a real-life setting.

Authors:  Phillipe van der Linden; Jacques Douchamps; Claude Schmitt; Dominique Forget
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

7.  Evaluation and implementation of strategies to reduce the intravenous admixture returns.

Authors:  Ahmed A Alrashed; Yahya Ali Mohzari; Syed Mohammed Basheeruddin Asdaq
Journal:  Saudi J Biol Sci       Date:  2020-11-11       Impact factor: 4.219

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.